Cure Parkinson’s Grant Supports Potential Iron-trapping Treatment

Cure Parkinson’s Grant Supports Potential Iron-trapping Treatment

287303

Cure Parkinson’s Grant Supports Potential Iron-trapping Treatment

Cure Parkinson’s is supporting AbFero Pharmaceuticals in its work to advance SP-420, a potential disease-modifying therapy for Parkinson’s disease that clears excess iron from the brain. The grant award supports further testing of AbFero’s lead compound in Parkinson’s models with a goal of moving it into clinical trials. SP-420, a next-generation iron chelator, is believed safer and more tolerable than earlier versions, the U.K. group reports. “AbFero is working urgently to develop best-in-class, next generation iron chelators that will slow progression…

You must be logged in to read/download the full post.